Phase 1 Study of PK and Safety of SPR206 in Subjects With Various Degrees Of Renal Function

Clinical trial NCT04865393 · COMPLETED

Trial details

NCT number: NCT04865393
Sponsor: Spero Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Renal Impairment

Start date: 2021-06-08
Primary completion: 2021-12-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.